ContraFect to Present at ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance August 22, 2018
ContraFect to Participate in FDA Workshop on Development of Non-Traditional Therapies for Bacterial Infections August 14, 2018
ContraFect to Present New Data on CF-301 (exebacase) and Lysins Targeting Gram-Negative Pathogens at ASM Microbe 2018 May 30, 2018
ContraFect to Present CF-301 Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) April 11, 2018
ContraFect Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update March 15, 2018
